NASDAQ:INSY
Delisted

Insys Therapeutics Stock Predictions

etoro logo Buy INSY
*Your capital is at risk
$0.255
+0 (+0%)
At Close: Sep 17, 2019
Currently predicting for Fri, 5 Jun 2026

INSY Prediction Chart

INSY Predictions History

Latest community submissions for INSY.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jun 17, 2019 $0.319 +8.10% $0.295 X 91.90% 0
joe1234 joe1234 Pro
May 20, 2019 $1.15 +20.02% $0.96 X 79.98% 0
JS JS Pro
May 14, 2019 $1.54 +24.19% $1.24 X 75.81% 0
joe1234 joe1234 Pro
May 14, 2019 $0.770 -37.90% $1.24 X 62.10% 0
May 6, 2019 $4.28 +0.47% $4.26 X 99.53% 4
joe1234 joe1234 Pro
May 3, 2019 $4.11 -1.91% $4.19 X 98.09% 0
Apr 30, 2019 $4.55 +5.81% $4.30 X 94.19% 0
JS JS Pro
Aug 9, 2018 $7.46 -0.27% $7.48 X 99.70% 4
John John @John.24618
Apr 26, 2018 $5.11 -30.38% $7.34 X 69.60% 0
JS JS Pro
Dec 27, 2017 $7.78 +0.13% $7.77 X 99.90% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for INSY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT INSYS THERAPEUTICS
Insys Therapeutics
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE